Citadel Advisors’s Zivo Bioscience, Inc. Warrants ZIVOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17,798
Closed -$7.97K 15622
2023
Q3
$7.97K Buy
17,798
+7,697
+76% +$3.86K ﹤0.01% 13230
2023
Q2
$5.05K Buy
+10,101
New +$6.22K ﹤0.01% 13537

Citadel Advisors's ZIVOW Position: Q4 2023 in Review

Citadel Advisors sold out of Zivo Bioscience, Inc. Warrants (ZIVOW) in Q4 2023, closing a stake of 17,798 shares — an estimated $7.97K sold.

Citadel Advisors first reported a position in ZIVOW in Q2 2023 and held it in 2 quarters. The position peaked at $7.97K in Q3 2023. 0 funds tracked by Wall St. Rank hold ZIVOW as of Q4 2023.

  • Citadel Advisors reported no remaining Zivo Bioscience, Inc. Warrants position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 17,798 Zivo Bioscience, Inc. Warrants shares in Q4 2023, an estimated $7.97K.
  • Citadel Advisors first reported a position in Zivo Bioscience, Inc. Warrants in Q2 2023 and held it in 2 quarters.
  • Citadel Advisors's Zivo Bioscience, Inc. Warrants position peaked at $7.97K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Warrants as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.